12(S)-HETrE is an endogenous metabolite produced by oxidation of omega-6 PUFA dihomo-gamma-linolenic acid (DGLA) by 12-lipoxygenase (12-LOX) in platelets, which acts on Galphas-coupled G-protein-coupled receptors, has antithrombotic properties, and has potential therapeutic use in cardiovascular disease. 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), alpha granule secretion, integrin alphaIIbbeta3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.
Molekulargewicht:
322.48
CAS Nummer:
[72710-10-2]
Formel:
C20H34O3
Target-Kategorie:
Others|||PKA|||Integrin|||Endogenous Metabolite
T36773
T36773
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten